Safety and Tolerability Outcomes of Investigational Drug Therapies in Controlled Clinical Trials
Samstein, R.M., Lee, CH., Shoushtari, A.N. et al. Safety and Tolerability Outcomes of Investigational Drug Therapies in Controlled Clinical Trials. Nat Genet 51, 202–206 (2019). https://doi.org/10.1038/s41588-018-0312-8
Dose–Response Relationships and Optimization Strategies in Clinical Drug Development
Aracena, K.A., Lin, YL., Luo, K. et al. Dose–Response Relationships and Optimization Strategies in Clinical Drug Development. Nat Genet 56, 408–419 (2024). https://doi.org/10.1038/s41588-024-01668-z
Characterizing Patient Response Variability in Multiphase Clinical Trials
Ma, PF., Liu, YL., Guo, C. et al. Characterizing Patient Response Variability in Multiphase Clinical Trials. Nat Genet (2024). https://doi.org/10.1038/s41588-024-01683-0
Long-Term Safety and Efficacy Trends Observed in Extended Drug Trial Follow-Up Studies
Yang, H., Wang, J., Didion, J. et al. Long-Term Safety and Efficacy Trends Observed in Extended Drug Trial Follow-Up Studies. Nat Genet 43, 648–655 (2011). https://doi.org/10.1038/ng.847
Clinical Trial Methodologies for Evaluating Emerging Therapeutic Agents
Kunkle, B.W., Grenier-Boley, B., Sims, R. et al. Clinical Trial Methodologies for Evaluating Emerging Therapeutic Agents. Nat Genet 51, 414–430 (2019). https://doi.org/10.1038/s41588-019-0358-2